Clear Street’s AEON Biopharma Inc AEON.WS Stock Holding History

Clear Street’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-6,218	Closed	-$9.02K	–	901
2024 Q1	$9.02K	Sell	6,218 -44,992	-88%	-$27.6K	﹤0.01%	438
2023 Q4	$5.12K	Hold	51,210	–	–	﹤0.01%	451
2023 Q3	$7.68K	Buy	51,210 +3,867	+8%	+$548	﹤0.01%	591
2023 Q2	$4.26K	Sell	47,343 -1,167	-2%	-$88	﹤0.01%	842
2023 Q1	$2.67K	Buy	48,510 +16,489	+51%	+$951	﹤0.01%	806
2022 Q4	$1K	Buy	32,021 +15,749	+97%	+$636	﹤0.01%	963
2022 Q3	$1K	Hold	16,272	–	–	﹤0.01%	1078
2022 Q2	$2K	Buy	16,272 +16,045	+7,068%	+$3.37K	﹤0.01%	874
2022 Q1	$0	Buy	+227	New	+$94	﹤0.01%	523

Clear Street's AEON.WS Position: Q2 2024 in Review

Clear Street sold out of AEON Biopharma Inc (AEON.WS) in Q2 2024, closing a stake of 6,218 shares — an estimated $9.02K sold.

Clear Street first reported a position in AEON.WS in Q1 2022 and held it in 9 quarters. The position peaked at $9.02K in Q1 2024. 0 funds tracked by Wall St. Rank hold AEON.WS as of Q2 2024.

Clear Street reported no remaining AEON Biopharma Inc position as of Q2 2024 after selling out during the quarter.
Clear Street sold 6,218 AEON Biopharma Inc shares in Q2 2024, an estimated $9.02K.
Clear Street first reported a position in AEON Biopharma Inc in Q1 2022 and held it in 9 quarters.
Clear Street's AEON Biopharma Inc position peaked at $9.02K in Q1 2024.
0 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q2 2024.

Based on Clear Street's 13F filing for Q2 2024, filed 12 Aug 2024.